Глобальна гаряча лінія для українських пацієнтів-біженців, які беруть участь у клінічному випробуванні Amgen. Натисніть тут для отримання додаткової інформації.
Глобальная горячая линия для украинских пациентов-беженцев, участвующих в клиническом исследовании Amgen. Для получения дополнительной информации нажмите здесь.
Science & Innovation 09.01.2022
Join host Rob Lenz, Amgen’s senior vice president of Global Development, in conversations with leading experts about the latest approaches in clinical trial design and execution.
Science & Innovation 08.30.2022
Take a look back at the innovative and inspiring scientists who shared their stories.
Science & Innovation 08.25.2022
Amgen announces long-term safety data of its PCSK9 inhibitor at the European Society of Cardiology conference in Barcelona.
Science & Innovation 08.18.2022
Responsibility 08.16.2022
How Amgen's largest manufacturing facility is leading the way on wastewater treatment and sustainability in the biotech industry.
Science & Innovation 08.10.2022
Amgen's long-running biotechnology exhibit gets a face lift at one of the world's largest museums of science and technology.
PRESS RELEASE
Amgen is a pioneer in the science of using living cells to make biologic medicines.
Amgen’s medicines treat serious illnesses and typically address diseases with a limited number of treatment options.
Making a positive difference in the world is at the heart of what we do at Amgen—and it goes beyond making vital medicines.
Amgen is a pioneer in the science of using living cells to making biologic medicines, leading and guiding the biotech industry.
Encounter opportunities both new and undiscovered, as we embrace leading-edge technologies, invest in our talents, and maximize our potential.
